Vanguard Global Advisers’s Cerenome CNSY Stock Holding History

Vanguard Global Advisers’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.97K	Sell	2,282 -1	-0%	-$5	﹤0.01%	3475
2026 Q1	$9.3K	Buy	+2,283	New	+$17.3K	﹤0.01%	3487

Other funds holding CNSY

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Global Advisers's CNSY Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Cerenome (CNSY) stake by 0.04% in Q2 2026, selling an estimated $5 and leaving 2,282 shares worth $9.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3475.

Vanguard Global Advisers first reported a position in CNSY in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

Vanguard Global Advisers held 2,282 shares of Cerenome worth $9.97K as of Q2 2026.
Vanguard Global Advisers sold 1 Cerenome share in Q2 2026, an estimated $5.
Cerenome made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3475 holding.
Vanguard Global Advisers first reported a position in Cerenome in Q1 2026 and has held it in 2 quarters since.
21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.